A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation

Brain Research

Volumn 1239, Issue , 2008, Pages 36-41

  Nunes, Ana ^a   Ohadi, Mina ^b   Rahimi, Alireza ^c   Aghajani, Ali ^b   Najmabadi, Hossein ^b   Currais, Antonio ^a   Soriano, Salvador ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^c Hamedan Research Institute of Behavioural Disorders and Substance Abuse   (Iran)

Author keywords

Calreticulin; Schizophrenia; Transcription

Indexed keywords

CALRETICULIN; LITHIUM; VALPROIC ACID;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN TISSUE; INHERITANCE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT; SCHIZOAFFECTIVE PSYCHOSIS; SCHOOL CHILD; TRANSCRIPTION INITIATION;

ADOLESCENT; ADULT; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; CEREBRAL CORTEX; CHILD; FAMILY; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; NEURONS; PHENOTYPE; POINT MUTATION; PROMOTER REGIONS, GENETIC; PSYCHOTIC DISORDERS; RATS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTIONAL ACTIVATION; VALPROIC ACID;

RATTUS;

EID: 54049117517     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.08.064     Document Type: Article

References (17)

1. Aghajani A., Rahimi A., et al. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia. Am. J. Med. Genet., B. Neuropsychiatr. Genet. 141 3 (2006) 294-295
2. Arion D., Unger T., et al. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 62 7 (2007) 711-721
3. Chen B., Wang J.F., et al. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biol. Psychiatry 48 7 (2000) 658-664
4. Corson T.W., Woo K.K., et al. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. Eur. Neuropsychopharmacol. 14 2 (2004) 143-150
5. Ferrer I., Gomez-Isla T., et al. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr. Alzheimer Res. 2 1 (2005) 3-18
6. Groenendyk J., Lynch J., et al. Calreticulin, Ca2+, and calcineurin - signaling from the endoplasmic reticulum. Mol. Cells 17 3 (2004) 383-389
7. Hamshere M.L., Bennett P., et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry 62 10 (2005) 1081-1088
8. Johnson S., Michalak M., et al. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol. 11 3 (2001) 122-129
9. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24 9 (2003) 441-443
10. Luo X., Weber G.A., et al. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J. Neuroimmunol. 135 1-2 (2003) 62-71
11. McCauliffe D.P., Yang Y.S., et al. The 5′-flanking region of the human calreticulin gene shares homology with the human GRP78, GRP94, and protein disulfide isomerase promoters. J. Biol. Chem. 267 4 (1992) 2557-2562
12. Michalak M., Corbett E.F., et al. Calreticulin: one protein, one gene, many functions. Biochem. J. 344 Pt 2 (1999) 281-292
13. Munoz-Montano J.R., Moreno F.J., et al. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411 2-3 (1997) 183-188
14. Sadock B., and Sadock V. Kaplan And Sadock's Comprehensive Textbook of Psychiatry (2004), Lippincott Williams & Wilkins
15. Waser M., Mesaeli N., et al. Regulation of calreticulin gene expression by calcium. J. Cell Biol. 138 3 (1997) 547-557
16. Williams D.B. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J. Cell. Sci. 119 Pt 4 (2006) 615-623
17. Yamazaki T., Muramoto M., et al. Suppressive effects of FR167653, an inhibitor of p38 mitogen-activated kinase, on calreticulin mRNA expression induced by endoplasmic reticulum stresses. Eur. J. Pharmacol. 484 2-3 (2004) 147-156